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Abstract
Background: The search for alternatives to antibiotics in pig production has increased the interest in natural
resources with antimicrobial properties, such as medium-chain fatty acids (MCFA) as in-feed additives. This study
evaluated the potential of a novel blend of MCFA salts (DIC) from distilled coconut oil with a lauric acid content to
reduce enteropathogens and control intestinal diseases around weaning. Two experimental disease models were
implemented in early-weaned piglets, consisting of two oral challenges: Salmonella Typhimurium (1.2 × 108 CFU)
or enterotoxigenic Escherichia coli (ETEC) F4 (1.5 × 109 CFU). The parameters assessed were: animal performance,
clinical signs, pathogen excretion, intestinal fermentation, immune-inflammatory response, and intestinal
morphology.
Results: The Salmonella challenge promoted an acute course of diarrhea, with most of the parameters responding
to the challenge, whereas the ETEC F4 challenge promoted a mild clinical course. A consistent antipathogenic
effect of DIC was observed in both trials in the hindgut, with reductions in Salmonella spp. plate counts in the
cecum (P = 0.03) on d 8 post-inoculation (PI) (Salmonella trial), and of enterobacteria and total coliform counts in
the ileum and colon (P < 0.10) on d 8 PI (ETEC F4 trial). When analyzing the entire colonic microbiota (16S rRNA
gene sequencing), this additive tended (P = 0.13) to reduce the Firmicutes/Bacteroidetes ratio and enriched
Fibrobacteres after the Salmonella challenge. In the ETEC F4 challenge, DIC prompted structural changes in the
ecosystem with increases in Dialister, and a trend (P = 0.14) to increase the Veillonellaceae family. Other parameters
such as the intestinal fermentation products or serum pro-inflammatory mediators were not modified by DIC
supplementation, nor were the histological parameters. Only the intraepithelial lymphocyte (IEL) counts were
lowered by DIC in animals challenged with Salmonella (P = 0.07). With ETEC F4, the IEL counts were higher with
DIC on d 8 PI (P = 0.08).
Conclusions: This study confirms the potential activity of this MCFA salts mixture to reduce intestinal colonization
by opportunistic pathogens such as Salmonella or E. coli and its ability to modulate colonic microbiota. These
changes could explain to some extent the local immune cell response at the ileal level.
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Background
In modern pig production, early weaning around 4 wk
of life is associated with an abrupt dietary change and
immature organ function, with a consequent reduction
in growth. Thus, piglets around the post-weaning period
are highly susceptible to enteric bacterial infections
caused by opportunistic pathogens. The use of antibi-
otics and other medications to circumvent this critical
period has been common in intensive systems; however,
it has contributed to the development of antibiotic-
resistant strains. Indeed, the last report from the Euro-
pean Food Safety Authority (EFSA) for the situation in
2015 documented an increase in multi-drug resistant
(MDR) strains of Escherichia coli and Salmonella Typhi-
murium [1]. There is therefore an urgent need to search
for alternatives that will diminish diarrhea outbreaks and
help to reduce the use of therapeutic and prophylactic
antibiotics.
Feeding strategies are one of the most commonly-used
management factors for the improvement of gut health
and function in newly weaned pigs. A wide range of bio-
active ingredients have been proposed as tools to control
enteric pathogens, to help reduce the incidence and se-
verity of digestive problems associated with weaning [2].
Among them, medium-chain fatty acids (MCFA), con-
sidered fatty acids with a chain length of 6- to 12- car-
bon atoms, have been proposed as a potential alternative
to antibiotics based on their long-known antibacterial
activity [3]. In contrast to antimicrobial agents, MCFA
have not shown evidence of acquiring resistance [4, 5].
Besides this, MCFA are an immediate source of energy
due to their rapid passive absorption and digestion,
which is of particular interest for the nutrition of young
animals [6, 7]. They occur naturally as medium-chain
triglycerides (MCT) in milk fat, as well as in other vege-
table sources, such as coconut or palm oils and Cuphea
seed oil [8, 9]. The most abundant MCFA in coconut is
lauric acid (C12), representing up to 45% of the coconut
fat content, followed by capric (C10) and caprylic (C8)
acids [10]. C12 acid has been proven to have the greatest
antimicrobial function among all MCFA [4, 11].
Several published works can be found substituting fat
sources with purified MCFA or alternative natural
sources rich in MCFA, leading to improvements in the
performance of piglets around weaning [12, 13]. Studies
with healthy pigs [14–16] have demonstrated positive ef-
fects on growth performance, digestibility, and intestinal
microbiota. The antibacterial effect has also been widely
demonstrated in vitro [3, 17], particularly against Sal-
monella or enterotoxigenic E. coli (ETEC), among other
pathogens [18, 19]. However, to our knowledge, most of
the in vivo studies testing the effect of MCFA against
pathogens were performed in rodents [5, 20] and chick-
ens [21]. Only two studies have tested the potential of
MCFA in challenged pigs; one tested the control of Sal-
monella in fatteners under commercial conditions [22]
and the other assessed the efficacy against an LPS chal-
lenge in an experimental trial with weanlings [23].
Within this context, the objective of this work was to
evaluate the potential of a combination of sodium salts
of medium-chain fatty acids distilled from coconut oil to
enhance the gut health of weaned piglets in the face of
diarrheic enteric diseases caused by Salmonella or ETEC
F4 in controlled clinical assays.
Methods
Two different experiments were performed to evaluate
the effect of the coconut distillates against an oral chal-
lenge with Salmonella Typhimurium (Trial 1) or ETEC
F4 (Trial 2). Both trials were performed at the Servei de
Granges i Camps Experimentals of the Universitat
Autònoma de Barcelona (UAB). The treatment, manage-
ment, housing, husbandry and slaughtering conditions
conformed to European Union Guidelines (Directive
2010/63/EU).
Animals, housing, and experimental design
The two trials were conducted following Biosafety Level
2 requirements with appropriate training of the involved
personnel. For the first trial, 56 male piglets from high
sanitary status farms were used. The (Landrace × Large
White) × Piétrain piglets originated from mothers with
negative Salmonella serology results; they were weaned
at 28 d of age and had an average body weight (BW) of
8.1 ± 1.16 kg. For the second trial, 72 male piglets
(Landrace × Large White) × Piétrain that originated
from mothers that were not vaccinated against E. coli
were used; they were weaned at 21 d of age and had an
average BW of 5.6 ± 0.95 kg.
The piglets were transported to the UAB facilities and
for each trial, 48 animals were placed in 16 pens (three
animals per pen). In each pen, the animals were distrib-
uted according to weight (a low-, an intermediate-, and
a high-weighted animal) to obtain a final homogenous
weight among pens. The experimental treatments were
evenly distributed among the pens. The experimental
treatments included a control treatment (CTR) consist-
ing of a plain diet without additives and the same diet
including a commercial blend of salts of MCFA distilled
from coconut oil (Dicosan) at 3 kg/t (DIC). The rest of
the animals were kept in a separate room and used as
controls for the challenges (placebo groups, PLB). For
the first trial, eight piglets were distributed among four
pens (two animals per pen), and for the second trial 24
piglets were distributed among eight pens (three animals
per pen). Both placebo groups received the same plain
diet given to the CTR groups and were euthanized at d
4 post-inoculation (PI).
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Each pen (3 m2) had a feeder and a water nipple to
provide feed and water for ad libitum consumption. The
weaning rooms were equipped with automatic heating
and forced ventilation. The experiments were conducted
during the autumn-winter seasons (September–October
and February–March for Trial 1 and 2, respectively) with
a mean room temperature of 30.8 ± 5.28 °C. Both trials
were maintained under a 13 h light/11 h dark lighting
regimen.
Experimental products and diets
The evaluated feed-additive is commercially available
(Dicosan) and was supplied by Norel S.A. (Madrid,
Spain). It consisted of a mixture of sodium salts of fatty
acid obtained from the distillates of coconut oil (67%
crude fat and a fatty acid profile with 48.4% lauric acid,
18.6% myristic acid, 9.9% palmitic acid, 6.8% oleic acid,
6.2% caprylic acid, 5.8% capric acid, 3.6% stearic acid
and 1.3% linoleic acid).
The basal diet (Table 1) was formulated to satisfy the
nutrient requirement standards for pigs [24]. For each
trial, the diet was manufactured in the same batch and
the additive was mixed with the corresponding amount
of feed to obtain the DIC diet. Dicosan was included ac-
cording to the manufacturer’s recommended dosage (3
kg/t). The intended dose of the additive was not analyt-
ically confirmed in the diet, however, it was expected to
provide 1.11 kg/t of lauric acid.
Bacterial strains
For the first trial, the Salmonella strain used for the oral
challenge was a monophasic variant of Salmonella Typhi-
murium (4,5,12:i:-) with a ACSSuT-Ge resistance profile
and phage type U302; it was isolated from a salmonellosis
outbreak in fattening pigs in Spain (mainly enteric with
sporadic septicemia) and provided by the Infectious
Diseases Laboratory of UAB (ref. 301/99). The oral inocu-
lum was prepared by overnight incubation at 37 °C and
250 r/min in buffered peptone water (BPW; Oxoid,
Hampshire, UK) and diluted (1:20) with sterile phosphate
buffered saline (PBS; Sigma-Aldrich, Madrid, Spain). The
final inoculum concentration was 5.8 × 107 CFU/mL. To
confirm the doses, serial dilutions of the inoculum were
cultured in tryptic soy agar (TSA; BD Difco, Heidelberg,
Germany) by overnight incubation at 37 °C.
For the second trial, the enterotoxigenic Escherichia
coli (ETEC) F4 strain used (positive for virulence factors
F4ab, F4ac, LT, STb, and EAST1 and negative for F6,
F18, F41, STa, VT1, VT2, and EAE) was isolated from
14-wk-old pigs and provided by the Diseases Laboratory
of UAB (ref. 30/14-3). The oral inoculum was prepared
by overnight incubation at 37 °C and 250 r/min in brain
heart infusion (BHI; Oxoid). The final inoculum was 2.5
× 108 CFU/mL. To confirm the doses, serial dilutions of
the inoculum were cultured in Luria agar (LA; Labora-
torios Conda, Torrejón de Ardoz, Spain) by overnight
incubation at 37 °C.
In both trials, the placebo animals received the same
amount of confirmed sterile broth inocula.
Experimental procedure
The animals received the experimental diets ad libitum
over 14 d in the Salmonella trial and 15 d in the ETEC
Table 1 Ingredient composition and chemical analysis of the




Barley 2 row 170
Extruded soybean 150
Sweet whey-powder (cattle) 112
Fishmeal LT 60.0
Soybean meal 47 70.0
Whey powder 50% fat 25.0
Mono-calcium phosphate 6.5
















Analyzed nutrients, g/kg Salmonella trial ETEC F4 trial
Dry matter 902 915
Ash 54.2 48.2
Crude fat 59.4 66.5
Crude protein 198 195
Neutral detergent fiber 84.3 81.7
Acid detergent fiber 31.1 31.5
aProvided per kilogram of complete diet: 10,200 IU vitamin A, 2,100 IU vitamin
D3, 39.9 mg vitamin E, 3 mg vitamin K3, 2 mg vitamin B1, 2.3 mg vitamin B2, 3
mg vitamin B6, 0.025 mg vitamin B12, 20 mg calcium pantothenate, 60 mg
nicotinic acid, 0.1 mg biotin, 0.5 mg folic acid, 150 mg Fe, 156 mg Cu, 0.5 mg
Co, 120 mg Zn, 49.8 mg Mn, 2 mg I, and 0.3 mg Se
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F4 trial. After 6 and 7 d of adaptation in the first and
second trials, respectively, the animals were orally chal-
lenged with the pathogen or the sterile broth. One pig
per pen was euthanized on d 4 and 8 PI. The PLB ani-
mals were maintained until d 4 PI and thereafter eutha-
nized following the same procedures performed on the
challenged groups.
Fecal samples for microbiological analysis were asep-
tically collected from the heaviest piglet from each pen
(n = 16) at arrival and after the adaptation period (d 0
PI), after spontaneous defecation or by rectal stimula-
tion. After the adaptation period, the pathogenic bacteria
inocula were administered by oral gavage to all animals
as a single dose of Salmonella Typhimurium (1.2 × 108
CFU) or ETEC F4 (1.48 × 109 CFU) on d 7 and 8, re-
spectively. In order to ensure that the stomach was full
at the time of inoculation and to facilitate bacterial
colonization, feed was withdrawn at 21:00 the previous
day and provided once again 30 min before inoculation
the following morning.
Individual BW and pen feed consumption were regis-
tered during the adaptation period. Body weight was fur-
ther recorded on d 0, 4, and 8 PI in both trials, whereas
feed consumption was recorded on d 0, 2, 4, and 8 PI
for the Salmonella trial and d 0, 1, 2, 3, 4, 5, 7, and 8 PI
for the ETEC F4 trial. The average daily gain (ADG) and
average daily feed intake (ADFI) were calculated per
pen, which was considered the experimental unit.
After the oral challenge, animals were checked daily
for clinical signs to evaluate their status (i.e. dehydration,
apathy, fecal score), always by the same individual. Mor-
tality was also registered. No antibiotic treatment was
administered to any of the animals in any of the experi-
ments. The fecal score was assessed using a scale: 1 =
solid and cloddy, 2 = soft with shape, 3 = very soft or
viscous liquid, and 4 = watery or with blood. A fecal
score was registered individually on d 0, 1, 2, 3, and 7 PI
in the Salmonella trial and on d 0, 1, 2, 3, 5, and 7 PI in
the ETEC F4 trial. Rectal temperature was assessed using
a digital thermometer (Accu-Vet, Import Vet S.A., Cen-
telles, Spain) on d 0 and 2 PI. Within the Salmonella
trial, additional fecal samples for microbiological analysis
were collected from the same animals on d 1, 3, and
7 PI.
On d 4 and 8 PI, one pig per pen was euthanized
sequentially during the morning (between 08:00 and 14:
00) for sampling. On d 4 PI, the animal from each pen
with the mid-weight at the beginning of the experiment
was selected, and on d 8 PI, the animal with the highest
weight was selected. A 10-mL blood sample was ob-
tained by venipuncture of the cranial vena cava using
10-mL tubes without anticoagulant (Aquisel, Madrid,
Spain). Immediately, the animals received an intravenous
injection of sodium pentobarbital (200 mg/kg BW;
Euthasol, Esteve, Barcelona, Spain). Once dead, the ani-
mals were bled, the abdomen was immediately opened,
and the intestinal tract was excised.
The digesta content from the ileum (5 cm from the
ileal-cecal junction) and proximal colon (5 cm from the
ceco-colic junction) was collected and homogenized, and
the pH was immediately determined using a pH-meter
calibrated on each day of use (Crison 52-32 electrode,
Net Interlab, Madrid, Spain). Different aliquots were col-
lected for different determinations. Samples of approxi-
mately 5 g were kept immediately on dry ice until being
stored at -20°C for the further analysis of short-chain
fatty acids (SCFA) and lactic acid, and similar aliquots
were stored at - 80°C for the high-throughput sequen-
cing (HTS) of colonic microbiota. Another set of sam-
ples were preserved in a H2SO4 solution (3 mL of
digesta plus 3 mL of 0.2 mol/L H2SO4) and stored at
-20°C until ammonia (NH3) determination.
In the ETEC F4 trial, additional aliquots (approxi-
mately 2 g) from the ileum and colon digesta were also
kept on ice for microbiological analysis and were proc-
essed in less than 4 h; other similar aliquots were stored
at -80°C for E. coli F4 quantification by real-time quanti-
tative PCR (qPCR) and for the HTS of colonic micro-
biota. In parallel, to analyze the bacteria attached to the
ileal mucus and epithelium, 15-cm long sections of the
ileum were excised, washed thoroughly three times with
sterile PBS, opened longitudinally, and scraped with a
microscope glass slide to obtain mucosa samples. One
aliquot was kept on ice for microbial analysis. In the case
of the Salmonella trial, additional cecum digesta samples
were collected, kept on ice, and processed in less than
4 h for Salmonella counts.
For the histological study, 3-cm long sections from the
distal ileum were removed, opened longitudinally,
washed thoroughly with sterile PBS, and fixed by
immersion in a formaldehyde solution 3.7–4% (PanReac,
Castellar del Vallès, Spain).
Blood samples were centrifuged (1500 × g for 15 min)
and the obtained serum was divided into different
aliquots and stored at - 20°C.
Analytical procedures
Chemical analyses of the diets including the content of
dry matter (DM), ash, crude protein, and diethyl ether
extract were performed according to the Association of
Official Agricultural Chemists standard procedures [25].
Neutral detergent fiber and acid detergent fiber were
determined according to the method of Van Soest
et al. [26].
For microbial counts of Salmonella spp. (Trial 1), the
cecum content and feces were suspended in buffered
peptone water (BPW; 1:10). The quantitative determin-
ation consisted of 10-fold serial dilutions in PBS seeded
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in Xylose-Lactose-Tergitol-4 agar (XLT4; Merck,
Madrid, Spain) and a count of H2S positive colonies and
morphology compatible with Salmonella spp. after 24 h
incubation at 37 °C. With this scheme, animals were
given a count level as follows: negative, for animals with
no Salmonella growth at 102 dilution (< 103 CFU/g
fresh matter [FM]); low, for animals with counts of
103 to 104 CFU/g FM; medium, for animals with
counts of 105 to 106 CFU/g FM; and high, for animals with
counts of 107 to 108 CFU/g FM.
For microbial counts of enterobacteria and total coli-
forms (Trial 2), the ileum and colon contents and feces
were suspended in PBS (1:10), serially diluted in Lac-
tated Ringer’s Solution (Sigma-Aldrich), and seeded in
MacConkey agar and Chromogenic agar (Oxoid), re-
spectively. The counts were read after 24 h of incubation
at 37 °C.
In addition, for microbial molecular analysis, DNA
was extracted from samples (approximately 250 mg) and
purified using the commercial QIAamp DNA Stool Mini
Kit (Qiagen, West Sussex, UK). Subsequently, its con-
centration and purity were checked using a NanoDrop
1000 Spectrophotometer (Thermo Fisher, Wilmington,
DE). The protocol was followed, applying all recom-
mended optimization steps, in order to improve bacterial
cell rupture and purity. The DNA was finally eluted in
200 mL of Qiagen buffer AE and stored at - 80 °C until
use.
E. coli F4 was quantified in colonic digesta and ileal
scrapings by qPCR using SYBR green dye. qPCR target-
ing the gene coding the F4 fimbria of ETEC F4 was per-
formed by modifying the procedure described by
Gustavo Hermes et al. [27]; the changes consisted of
using SYBR Green PCR Master Mix PCR (Applied Bio-
systems, Carlsbad, CA) and reducing the total volume of
the reaction to 20 μL, which included 10 μL of 2× SYBR
Green PCR Master Mix PCR buffer, 0.88 μL of each pri-
mer (12.5 μmol/L), and 5 μL of the DNA sample.
In the case of the HTS of the colonic microbiota in
both trials, the V3-V4 region of 16S rRNA was targeted
using MiSeq® Reagent Kit v2 (500 cycles; MiSeq from
Illumina, San Diego, CA). The primers used in the
construction of the libraries with amplicons of putative





The sequence reads of the 16S rRNA gene generated
from the MiSeq Illumina system were processed using
the QIIME v.1.9.1 pipeline [28] with default settings.
The quality filter of the already demultiplexed sequences
was performed at a maximum unacceptable Phred qual-
ity score of Q20. The resulting reads were clustered to
operational taxonomic units (OTUs) using uclust with
97% sequence similarity and a subsampling pick open
reference method [29] at 10%. Representative sequences
were assigned to taxonomy against the bacterial 16S
GreenGenes v.13.8 reference database [30] at a 90% con-
fidence threshold, and sequence alignment and phylo-
genetic tree building were performed using uclust and
FastTree, respectively. Thereafter, chimeric sequences
were removed with ChimeraSlayer [31] using the default
settings and further quality filtering consisted of remov-
ing singletons and OTUs with a relative abundance
below 0.005% across all samples, as recommended by
Bokulich et al. [32].
The ammonia (NH3) concentration was determined
with the aid of a gas-sensitive electrode (Hach Co., Love-
land, CO), combined with a digital voltmeter (Crison
GLP 22, Crison Instruments S.A., Barcelona, Spain),
modified from Barba-Vidal et al. [33]. Three grams of
digesta preserved in H2SO4 (1:2) was centrifuged at 1372
× g for 10 min. A supernatant was obtained and neutral-
ized with 1 mL of 10 mol/L NaOH to reach a pH of 11,
while stirring and measuring the ammonia released as
different voltages in mV.
The SCFA and lactic acid concentrations were deter-
mined based on the method described by Richardson
et al. [34] and modified by Jensen et al. [35] using gas
chromatography after submitting the samples to an
acid-base treatment, followed by a diethyl ether ex-
traction and derivatization with N-(tertbutyldimethyl-
silyl)-N-methyl-trifluoroacetamide (MBTSTFA) plus
1% tert-butyldimethylchlorosilane (TBDMCS) agent
(Sigma-Aldrich).
Tissue samples for morphological measures were
dehydrated and embedded in paraffin wax, sectioned to
4-μm thick slices and stained with hematoxylin and
eosin. The morphological measurements (villus height
and crypt depth, counts of intra-epithelial lymphocytes
and goblet cells in the villus, and counts of mitoses in
the crypt) of 10 different villus-crypt pairs were per-
formed using a light microscope (Leica DM5000B,
Jenoptik, Barcelona, Spain) fitted to CapturePro software
(ProgRes®, Jenoptik, Barcelona, Spain), using the tech-
nique described by Nofrarías et al. [36].
Serum concentrations of tumor-necrosis factor-α
(TNF-α) were determined using Quantikine Porcine
TNF-α kits (R&D Systems, Minneapolis, MN); the pig-
major acute-phase protein (Pig-MAP) concentration was
determined using a sandwich-type ELISA (Pig MAP Kit
ELISA, Pig CHAMP Pro Europe S.A., Segovia, Spain). In
the Salmonella trial, serological antibodies of Salmonella
were tested using ELISA Herdchek Swine Salmonella
(IDEXX, Hoofdorp, Netherlands).
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Statistical analysis
The effect of the experimental treatments on the per-
formance and slaughter measurements was determined
using the free software R v.3.4.3, using the stats package
[37] lm function for a one-way ANOVA, with diet as a
fixed effect. For the microbial analysis, in Trial 2, entero-
bacteria and coliform counts were log10-transformed
and submitted to the same one-way ANOVA analysis. In
the case of Trial 1, Salmonella spp. count levels were an-
alyzed with the stats package likelihood.test function for
frequency analysis; the number of positive animals for
Salmonella spp. followed the stats package glm function
under a binomial distribution. The Pig-MAP concentra-
tion levels were also analyzed with the same frequency
analysis, considering the normal range (0.3–1 mg/mL),
borderline (1–2 mg/mL), and high levels (> 2 mg/mL)
[38], and the number of animals with detectable copies
of the pathogen F4 gene or quantifiable levels of fermen-
tation products (SCFA and lactic acid) were analyzed
under a binomial distribution.
The average daily feed intake, rectal temperature, and
daily fecal consistency were assessed using the lme4
package [39] lmer function for an adjusted linear mixed
model, with a treatment-by-time interaction term.
For all analyzed data, the pen was the experimental
unit. The alpha level for the determination of signifi-
cance for all the analyses was 0.05. Statistical trends
were also considered for 0.05 < P < 0.10, unless other-
wise indicated. Data are presented as means and residual
standard error (RSE).
Biostatistics of quality-filtered sequences were per-
formed using the open source software R v.3.4.3. Firstly,
an OTU table was imported into R with the phyloseq
package [40]; only OTUs that were shared among ex-
perimental groups were included and unique OTUs were
excluded. Diversity and ordination (non-multidimen-
sional scaling, NMDS) were analyzed at the OTU level
using the vegan package [41]. The richness and alpha di-
versity were calculated with raw counts based on the
Chao1 estimator [42] to estimate the number of taxa in
the community, and the Shannon index [43], which con-
siders the richness as well as the evenness. For beta di-
versity, the Whittaker distance matrix was calculated
based on the relative abundances using the betadisper
function. To compare any differential effects from treat-
ments, an ANOVA was performed for richness and di-
versity. For ordination analysis, a dissimilarity matrix
based on the Bray-Curtis distances was also calculated
with relative abundances and two different fitting model
analyses were applied. The function envfit, which fits
centroids of class variable levels defined as a factor onto
an ordination, was used, and the anosim function was
used for the analysis of similarities (ANOSIM). Finally, a
differential abundance analysis was performed with the
OTU and taxa relative abundances under a zero-altered
negative binomial or negative binomial model with pscl
[44] and mass [45] packages, respectively, and corrected
for the false-discovery rate (FDR).
Results
In both studies, the animals showed a good health status
on arrival, with most of the animals adapting to the facil-
ities and feed positively. Both challenges promoted a
clinical course of diarrhea in most of the animals, who
were recovering spontaneously at the end of the study.
Some casualties were registered in both trials. After the
Salmonella challenge, one animal from the DIC group
was found dead on d 4 PI and two animals from the
DIC and CTR groups, respectively, were found dead on
d 6 PI. Within the ETEC F4 challenge, one animal from
the CTR group was found dead on d 1 PI and a second
animal from the DIC group had to be euthanized follow-
ing the clinical flowchart on d 3 PI. There were no stat-
istical differences in the number of causalities between
the treatments (P > 0.05) in any of the trials.
Animal performance
The effects of the experimental treatments on animal
performance are shown in Table 2. There were no sig-
nificant effects on the final BW, ADFI, or ADG with the
administration of DIC in any of the trials, except for a
lower ADG (P = 0.032) for the DIC group than the CTR
Table 2 Effect of the experimental diets on animal performance
in the Salmonella and ETEC F4 trials
Items Salmonella Trial ETEC F4 Trial
CTR DIC RSE P CTR DIC RSE P
BW, kg
Initial 8.1 8.1 0.14 0.900 5.6 5.6 0.10 0.239
Final 10.8 9.9 0.12 0.164 7.8 7.6 0.69 0.553
ADFI, g/d
PreIa 233 226 28.1 0.598 178 162 38.4 0.431
4 PIb 218 193 46.7 0.302 219 211 45.8 0.729
8 PIc 428 443 79.5 0.713 282 276 82.0 0.894
Overalld 285 278 41.5 0.766 221 211 46.6 0.664
ADG, g/d
PreIa 122 109 60.7 0.675 77 78 41.6 0.986
4 PIb -4 -38 108.7 0.541 129 117 90.5 0.796
8 PIc 326 316 162.6 0.903 260 164 80.6 0.032
Overalld 144 126 70.9 0.616 140 111 43.3 0.207
ADFI Average daily feed intake, ADG Average daily gain, BW Body weight, PI
Post-inoculation day, RSE Residual standard error
aPre-inoculation period from 0–7 d or 0–6 d before inoculation in the
Salmonella and ETEC F4 trials, respectively
bPeriod from 0–4 d post-inoculation
cPeriod from 4–8 d post-inoculation
dPeriod from experimental day 1–14 or 1–15 in the Salmonella and ETEC F4
trials, respectively
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group during the second PI period (4–8 d PI) in the
ETEC F4 trial. Regarding the performance response in
the PLB groups, in the Salmonella trial the ADG was 33
± 76.0 g/d during the adaptation week, and 306 ± 92.3
g/d during the 4-PI period, whereas in the ETEC F4,
these values were 75 ± 42.9 g/d and 174 ± 63.8 g/d, re-
spectively. The ADFIs observed in the first trial for the
PLB group were 184 ± 26.4 g/d and 379 ± 71.2 g/d dur-
ing the pre- and post-inoculation days, respectively, and
those in the second trial for the PLB groups were 187 ±
59.8 g/d and 255 ± 24.6 g/d, respectively.
Clinical signs
The evolution of the fecal consistency throughout the
post-inoculation (PI) period is presented in Fig. 1. After
the oral challenge, fecal consistencies were impaired in
both trials. The inoculation of Salmonella led to an
evident liquid diarrhea (time P < 0.001), with scores
reaching level 3 in most of the animals on d 2 PI. After
the ETEC inoculation, diarrhea was observed (time
P = 0.015) in a limited number of animals (barely
reaching scores of 1.8). There were no significant differ-
ences related to the experimental diets for any of the trials
(P > 0.31).
The Salmonella challenge increased the rectal
temperature (40.6 ± 0.27 °C on d 2 PI vs. 39.4 ± 0.22 °C
on d 0 PI; day P < 0.001). The ETEC F4 challenge did not
affect this variable (39.1 ± 0.35 °C on d 2 PI vs. 39.0
± 0.24 °C on d 0 PI; day P = 0.21). In relation to the
effect of diets, DIC had no significant influence on
rectal temperature (P > 0.6).
Inflammatory response
After the Salmonella challenge, the CTR group pre-
sented higher concentrations of TNF-α (312 ± 129.2 pg/
mL vs. 106 ± 15.9 pg/mL in PLB) and Pig-MAP (3.08 ±
2.812 mg/mL vs. 0.53 ± 0.140 mg/mL in PLB) on d 4 PI
than the PLB groups. After the ETEC challenge, a higher
response of both biomarkers was also observed in CTR
groups than the PLB groups (156 ± 52.1 pg/mL in CTR
vs. 123 ± 17.4 pg/mL in PLB, and 1.56 ± 1.545 mg/mL
in CTR vs. 1.22 ± 1.055 mg/mL in PLB, for TNF-α and
Pig-MAP, respectively). As expected, from day 4 to 8 PI,
the TNF-α (149 ± 69.2 pg/mL and 113 ± 20.3 pg/mL for
Trial 1 and 2, respectively) and Pig-MAP concentrations
(0.96 ± 0.469 mg/mL and 1.46 ± 0.417 mg/mL for Trial
1 and 2, respectively) were decreased in the CTR groups.
We were not able to detect statistical differences related
to the experimental diets for any of the variables on any
sampling day.
Microbiological analysis
In the Salmonella trial, none of the animals seeded Sal-
monella in their feces on arrival nor after the 6 d of
adaptation. The serological analysis from day 4 PI con-
firmed that the animals had not been exposed to Sal-
monella prior to the inoculation. PLB group remained
negative for Salmonella spp. until d 4 PI. Only one piglet
per group (CTR and DIC) seroconverted on d 8 PI by
applying a cut-off of an optical density percentage
(OD%) ≥ 40. Regarding the pathogen loads, all animals
became positive, however, not all animals seeded count-
able numbers of the pathogen (> 103 CFU/g FM). Sup-
plementation with DIC reduced the number of animals
with countable numbers in their cecum content, particu-
larly on d 8 PI (Table 3).
Figure 2 shows the different levels of Salmonella spp.
excretion in the feces and cecal content for the experi-
mental diets. Although the differences were not statisti-
cally significant, there was a trend for DIC to increase
the Salmonella counts in feces shortly after inoculation
(d 1 PI, P = 0.10; and d 3 PI, P = 0.09), but to clear the
pathogen more efficiently from the cecum on day 4 PI
than the CTR group (P = 0.07). At the end of the study
Fig. 1 Fecal scores throughout the post-inoculation (PI) period in the Salmonella (a) and ETEC F4 (b) trials. The fecal score was measured using a
scale from 0 (hard and cloddy) to 4 (watery or with blood). CTR control group, DIC Dicosan-supplemented group, PI post-inoculation day, PLB
placebo group
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(d 8 PI), there was also an increase in the number of ani-
mals with unquantifiable counts (very low) in the cecum
with the DIC treatment (63% vs. 12% for DIC and CTR,
respectively; P = 0.26).
Regarding the ETEC F4 trial, there were no significant
differences related to the experimental trials in the entero-
bacteria nor coliform plate counts in the feces upon arrival
or from after the week of adaptation (9.77 ± 0.282 and 9.70
± 0.360 log10 CFU/g FM, respectively). Table 4 shows the
microbiological analysis on d 4 and 8 PI of the ileal and co-
lonic digesta, and also of the ileal mucosa scrapings. On d 4
PI, the counts of both bacterial groups were not different
between the diets. However, on d 8 PI, animals receiving
DIC consistently had reduced numbers of enterobacteria
and coliforms in their ileum and colon content compared
to those who received the CTR treatment. This effect was
particularly apparent in the ileum, with decreases of more
than one log10 unit (5.38 vs. 6.71 log10 CFU/g FM, P =
0.004; and 5.33 vs. 6.51 log10 CFU/g FM, P = 0.05) for
enterobacteria and coliforms, respectively. The attached
enterobacteria in the ileal mucosa also tended to be re-
duced with DIC on d 8 PI compared to the CTR diets (P =
0.08).
The pathogen was not always present at quantifiable
levels (limit of detection 3.83 log10 F4 gene copies/g
FM). A slight trend was found between the diets on d 4
PI in terms of the prevalence of the pathogen (P = 0.10),
with all the CTR animals (8/8 animals) but not all from
the DIC treatment (6/8 animals) being positive for E. coli
F4 in the colon digesta. On day 8 PI, the pathogen pres-
ence was reduced in both groups, with no significant dif-
ferences between them (P = 0.30; 2/8 vs. 4/8 animals for
CTR and DIC, respectively), and similar loads (5.11 and
5.24 log10 F4 gene copies/g FM for the CTR and DIC
groups, respectively). In the PLB group, the number of
animals positive for E. coli F4 on day 4 PI was 5/8 with
mean count of 3.23 log10 F4 gene copies/g FM, which is
below the limit of detection.
Microbiota 16S rRNA gene analysis
With the objective of assessing changes promoted by the
additives to the intestinal microbiota, we analyzed co-
lonic digesta samples taken on d 8 PI by high-
throughput sequencing (HTS) of the V3-V4 regions of
the 16S rRNA gene.
The microbiota analysis was performed using a more
conservative approach, by using the OTU core, including
only those species shared between experimental treat-
ments, within each experiment (836/843 OTUs in Trial
1 and 833/848 OTUs in Trial 2). Regarding the evenness
of the reads, similar values were obtained when compar-
ing treated groups to CTR ones (P > 0.34; 4.94 ± 0.375
and 4.82 ± 0.243 log10 no. reads/sample in Trial 1 and
Table 3 Effect of the experimental diets on the numbers of




1 PI 7/8 8/8 0.228
3 PI 8/8 6/8 0.080
7 PI 3/8 2/8 0.589
Cecum digesta
4 PI 8/8 5/7 0.065
8 PI 7/8 3/8 0.033
PI post-inoculation day
aNumber of animals with countable numbers of Salmonella spp. (< 103 log10
CFU/g FM)
Fig. 2 Number of animals with different levels of Salmonella spp. counts in feces and cecal contents. Feces sampled on d 1 (a), 3 (b), and 7 (c)
post-inoculation (PI), and cecal content on d 4 (d) and 8 (e) PI (Salmonella trial). Range levels: negative (0 CFU/g), very low (< 103 CFU/g), low
(103–104 CFU/g), high (105–106 CFU/g), and very high (107–108 CFU/g)
López-Colom et al. Journal of Animal Science and Biotechnology           (2019) 10:89 Page 8 of 17
Trial 2, respectively). The Chao1 index did not differ
between the groups (P > 0.74).
Regarding the microbial diversity or structure, DIC
administration did not alter the alpha or beta diversity
(Whittaker index) after Salmonella inoculation. After
ETEC F4 inoculation, however, DIC administration did
change the Bray–Curtis distances (microbial structure)
as shown in Fig. 3 for the NMDS results (envfit P =
0.035 and ANOSIM P = 0.177).
Focusing on the aggregated taxa counts, Firmicutes
and Bacteroidetes were the two major phyla (≥ 40%),
with Proteobacteria following thereafter (7.3 ± 4.25% in
the Salmonella trial and 9.1 ± 5.30% in the ETEC F4
trial). A few minor phyla (< 1%): Elusimicrobia, Fibro-
bacteres, Lentisphaerae, and Verrumicrobia, were en-
countered in the Salmonella-challenged animals.
The majority of the families observed in both trials were,
by order of abundance: Prevotellaceae (27.9 ± 10.68% and
29.0 ± 7.52% in Trial 1 and 2, respectively), Veillonellaceae
(22.7 ± 9.55 % and 15.4 ± 5.32 % in Trial 1 and 2, respect-
ively), Rumminococcaceae (11.4 ± 3.42% and 11.4 ± 2.63%
in Trial 1 and 2, respectively) and Lachnospiraceae (8.29 ±
3.555 % and 9.25 ± 3.307 % in Trial 1 and 2, respectively);
41 and 42 different families were detected per trial, re-
spectively, representing approximately 5 % of the sum of
the least abundant ones (< 1%, 31 families per trial).
Among the genera detected, Prevotella was the most
prevalent (28.0 ± 10.7% and 29.0 ± 7.52% in Trial 1 and 2,
respectively). A total of 55 genera were found in the Sal-
monella and 54 in the ETEC F4 trials, and 40 and 42 gen-
era were underrepresented (< 1%) in Trial 1 and 2,
respectively, accounting for approximately 8 % of the total
abundance. Unknown taxa represented 7.2 ± 2.87% and
6.7 ± 2.05 % of the families in the Salmonella and ETEC
F4 trials, respectively, whereas they represented 24.8 ±
6.63 % and 27.2 ± 4.72% of the genera, respectively.
Fig. 3 Non-metric dimensional scaling (NMDS) plot of the
dissimilarity matrix based on Bray-Curtis distance. Clustering by
experimental diets for the Salmonella (a) and ETEC trial (b) from
colon digesta samples collected on day 8 post-inoculation (PI). CTR
control group, DIC Dicosan-supplemented group
Table 4 Effect of the experimental diets on enterobacteria and
coliform counts in the ETEC F4 trial
Items ETEC F4 trial
CTR DIC RSE P
Ileum digesta
Enterobacteria, log10 CFU/g FM
4 PI 6.81 6.76 0.616 0.872
8 PI 6.71 5.38 0.783 0.004
Coliforms, log10 CFU/g FM
4 PI 6.02 6.08 0.923 0.889
8 PI 6.51 5.33 0.829 0.013
Colon digesta
Enterobacteria, log10 CFU/g FM
4 PI 10.7 9.9 1.16 0.213
8 PI 10.9 9.9 1.03 0.083
Coliforms, log10 CFU/g FM
4 PI 8.9 8.9 0.99 0.974
8 PI 10.8 9.8 0.98 0.052
Ileum mucosa
Enterobacteria, log10 CFU/g FM
4 PI 5.94 6.32 0.860 0.383
8 PI 6.17 5.16 0.786 0.082
Coliforms, log10 CFU/g FM
4 PI 5.53 5.47 1.117 0.921
8 PI 5.48 5.09 1.093 0.489
CFU Colony-forming units, FM Fresh matter, PI Post-inoculation day, RSE
Residual standard error
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Regarding the influence of DIC, the Firmicutes:Bacteroi-
detes (F/B) ratio showed a trend of a numerical decrease
(P = 0.132) in the Salmonella trial with DIC (1.14 vs. 1.47
in the CTR group). In the ETEC F4 trial, F/B ratio was un-
affected (1.23 vs. 1.05 in the CTR group, P = 0.335).
The effects of DIC on specific populations are also
presented in Table 5, considering only the taxa found in
at least half of the samples. At the phylum level, under
the Salmonella challenge, only the minor phylum Fibro-
bacteres (< 1%) was increased in DIC-supplemented ani-
mals compared to the CTR (P = 0.02) animals. In
parallel, the corresponding family and genus, Fibrobac-
teraceae and Fibrobacter, respectively, were enriched in
the DIC animals compared to the CTR animals (P <
0.05). Other changes in the Salmonella trial were also
observed in minor families (< 1%), such as lower num-
bers of the candidate Barnesiellaceae and also in genera
such as Dialister, Lachnobacterium and Butyrivibrio (P <
0.10). Although not significant, there was a relevant nu-
merical decrease in the abundance of the Enterobacteria-
ceae family in DIC animals compared to in the CTR
animals (P = 0.16).
When considering the changes produced at the OTU
level, i.e., species, only those found in at least half of the
samples were considered. Table 6 presents the differ-
ences promoted by DIC (P < 0.05). As observed in the
aggregated taxa, in the Salmonella trial, several OTUs
assigned to Lachnospiraceae (new refs. OTU-2808 and
2343, and OTU-296082) were proportionally lower in
DIC animals than CTR animals, including the Lachno-
bacterium genus (OTU-584463). In addition, a
Spirochaetes-associated OTU was promoted in DIC ani-
mals (OTU-300859) and, in addition, several OTUs as-
sociated with Prevotella (within Bacteroidetes) were
increased in DIC animals, possibly explaining the previ-
ously mentioned reduction in the F/B ratio. Nonetheless,
other OTUs also corresponding to Bacteroidetes were in
lower numbers, which highlights the high variability
within a taxonomic group and the importance of consid-
ering the strain.
When focusing on populations under the ETEC F4
challenge (Table 5), few changes were observed in DIC-
supplemented animals; Dialister (P = 0.008) was signifi-
cantly increased and Lachnospira tended to be reduced
Table 5 Ln changes in taxa promoted by DIC supplementation in the Salmonella and ETEC F4 trials
Taxonomic rank Taxon Ln changea (DIC vs. CTR) Adjusted Pb
Salmonella trial
Phylum Fibrobacteres 2.229 0.019
Family cand. Barnesiellaceae -4.499 0.003
Fibrobacteraceae 2.229 0.024
Enterobacteriaceae - 1.746 0.157
Spirochaetaceae 1.326 0.192
Alcaligenaceae 0.876 0.192
Genus Dialister - 0.690 0.000
Fibrobacter 2.225 0.033
Lachnobacterium - 3.219 0.035
Butyrivibrio - 1.251 0.095
ETEC F4 trial
Family Veillonellaceae 0.363 0.136
Oxalobacteraceae - 0.804 0.151
Deferribacteraceae 1.915 0.151
Turicibacteraceae - 1.384 0.176
Genus Dialister 5.981 0.008
Lachnospira - 0.841 0.069
Megasphaera 1.137 0.149
Coprococcus - 1.051 0.149
Oxalobacter - 0.804 0.173
Mucispirillum 1.915 0.173
Turicibacter - 1.384 0.183
aPositive values and negative values indicate higher and lower abundance, respectively, in treated animals. Taxa are sorted by level of significance (from higher to
lower). The presented differences are based only on taxa detected in at least half of the samples per diet
bAdjusted P value < 0.20
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Table 6 Differentially abundant OTUsa between the DIC and CTR groups in the Salmonella and ETEC F4 trials
Taxonomic classificationb OTU code CTR DIC
Salmonella trial
Bacteroidetes; Prevotellaceae; Prevotella 300859 0.480 0.701
Firmicutes; Lachnospiraceae; Lachnospira 349257 0.273 0.175
Firmicutes; Clostridiales New ref. 2497 0.005 0.089
Unassigned New ref. 6586 0.005 0.062
Firmicutes; Erysipelotrichaceae 225636 0.055 0.002
Bacteroidetes; cand. Barnesiellaceae 315846 0.048 0.003
Bacteroidetes; Bacteroidaceae; Bacteroides ovatus 535375 0.039 0.015
Bacteroidetes; cand. Paraprevotellaceae; cand. Prevotella New ref. 6366 0.065 0.052
Firmicutes; Christensenellaceae 410242 0.001 0.024
Spirochaetes; Sphaerochaetaceae; Sphaerochaeta 1832447 0.003 0.017
Bacteroidetes; Bacteroidales New ref. 2311 0.003 0.025
Firmicutes; Clostridiales 357471 0.012 0.033
Bacteroidetes; Prevotellaceae; Prevotella stercorea New ref. 1872 0.008 0.033
Bacteroidetes; Prevotellaceae; Prevotella New ref. 1748 0.009 0.022
Bacteroidetes; Prevotellaceae; Prevotella 296082 0.008 0.023
Firmicutes; Lachnospiraceae; Lachnobacterium 584463 0.017 0.001
Bacteroidetes; Prevotellaceae; Prevotella stercorea New ref. 2808 0.001 0.008
Bacteroidetes; cand. Paraprevotellaceae; cand. Prevotella New ref. 648 0.002 0.009
Bacteroidetes; Prevotellaceae; Prevotella stercorea 302538 0.025 0.021
Firmicutes; Lachnospiraceae; Blautia 526773 0.014 0.013
ETEC trial
Bacteroidetes; Prevotellaceae; Prevotella stercorea 524371 2.430 1.654
Firmicutes; Clostridiales 584083 0.210 0.261
Firmicutes; Veillonellaceae; Megasphaera 298050 0.038 0.220
Firmicutes; Lachnospiraceae; Coprococcus 344804 0.032 0.318
Firmicutes; Veillonellaceae; Dialister 403701 0.001 0.056
Bacteroidetes; Bacteroidaceae; Bacteroides 513445 0.006 0.084
Bacteroidetes; Prevotellaceae; Prevotella 248447 0.049 0.046
Bacteroidetes; S24-7 844589 0.004 0.040
Bacteroidetes; Bacteroidales; cand. Paraprevotellaceae; YRC22 289468 0.034 0.030
Bacteroidetes; Prevotellaceae; Prevotella New ref. 2220 0.021 0.014
Firmicutes; Erysipelotrichaceae 287798 0.026 0.026
Firmicutes; Veillonellaceae; Megasphaera 264967 0.017 0.011
Bacteroidetes; cand. Paraprevotellaceae; cand. Prevotella New ref. 5084 0.008 0.004
Firmicutes; Clostridiales 798164 0.010 0.011
Firmicutes; Ruminococcaceae 583134 0.008 0.013
Firmicutes; Lachnospiraceae; Lachnospira 843553 0.399 0.140
Firmicutes; Lachnospiraceae; Coprococcus 366623 0.282 0.000
Firmicutes; Clostridiales 826624 0.143 0.081
aMean relative abundances (%) are presented for OTUs with an adjusted P value < 0.05 and detected in at least half of the animals per diet
bOrder is specified only when it represents the lowest rank classification
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(P = 0.069) compared to CTR animals. Other bacteria
were numerically altered (P < 0.20) by DIC, with most of
them representing < 1%, with the exception of Veillonel-
laceae (P = 0.136; approximately 15%) and the genus
within Megasphaera (P = 0.149; approximately 5%).
Intestinal fermentation products
Table 7 shows the modifications of the pH and the main
fermentation products in the ileum and colon digesta for
both trials. The ileal pH was not significantly modified
by the experimental treatments, except for a numerical
reduction (7.00 vs. 7.20; P = 0.11) observed for DIC
compared to CTR on d 4 PI in the Salmonella trial. In
the ileum, the major product of fermentation was lactic
acid, with ranges of 1.80–117 and 1.98–105 μmol/g FM
in Trial 1 and 2, respectively. No differences were de-
tected between the diets. Acetic acid was found at very
low levels in the ileum in both trials (average values of
1.61 and 4.44 μmol/g FM for Trial 1 and 2, respectively),
with several animals below the minimum detection level
on d 8 PI (12 for Trial 1 and 3 for Trial 2), and no differ-
ences between the experimental diets.
Regarding the colon digesta, there were no obvious
changes in pH, despite a slight reduction with DIC on d 4
PI in the Salmonella trial (6.70 vs. 6.92; P = 0.14). The am-
monia content was also not modified by the experimental
diets. The total SCFA content was not modified by the ex-
perimental diets, but showed an increase from d 4 to 8 PI
in both trials (from 92.7 to 141 and 104 to 159 μmol/g
FM, respectively). The fermentation profile showed few
changes with the diets; a numerical trend was observed in
the Salmonella trial (P = 0.12) for an increase in the valeric
acid proportion in the colon with DIC detected on d 4 PI.
In the ETEC trial, higher valeric concentrations were also
observed with DIC supplementation than with CTR diets
on d 8 PI (P = 0.03).
Ileal histomorphometry
Table 8 shows the changes promoted by the experimen-
tal diet in terms of ileal histomorphometry. The villus
height showed a marked increase from d 4 to 8 PI in
both trials, but was not modified by the experimental di-
ets, neither were the crypt depth or the villus:crypt ratio.
There were no differences related to the inclusion of
DIC either for the number of mitoses or the number of
goblet cells. However, intriguingly, the IEL counts dis-
played a trend to decrease with DIC in the Salmonella
trial on d 8 PI (P = 0.07), whereas these were increased
(P = 0.08) with the additive in the ETEC F4 trial.
Discussion
The present study aimed to evaluate the possible anti-
microbial effect of a mixture of medium-chain fatty acids
(MCFA) salts from coconut distillates (DIC) against en-
teric pathogens, such as Salmonella Typhimurium or
ETEC F4, and the consequent reinforcement of the gut
health and general health status of early-life weaned pig-
lets. In order to fulfill these objectives, DIC was adminis-
tered in feed in two different trials, each with one of the
two pathogens. In both trials, animals exhibited signs of
diarrhea after the oral challenge and an immediate de-
crease in feed intake.
Table 7 Effects of the experimental diets on intestinal
fermentation parameters in the Salmonella and ETEC F4 trials
Items Salmonella Trial ETEC F4 Trial
CTR DIC RSE P CTR DIC RSE P
Ileum digesta
pH
4 PI 7.20 7.00 0.228 0.111 6.81 6.80 0.208 0.891
8 PI 7.37 7.34 0.190 0.786 6.86 6.77 0.195 0.346
NH3, μmol/g
4 PI 4.4 2.0 2.77 0.113 0.6 1.4 1.91 0.431
8 PI 14.6 19.1 8.89 0.326 1.0 1.1 0.39 0.752
Lactic acid, μmol/g
4 PI 10.5 29.8 29.17 0.207 23.2 27.7 18.91 0.652
8 PI 41.8 23.4 27.09 0.196 19.1 36.0 25.73 0.209
Colon digesta
pH
4 PI 6.93 6.70 0.274 0.137 6.26 6.37 0.238 0.360
8 PI 7.07 7.04 0.156 0.671 5.97 6.07 0.266 0.464
NH3, μmol/g
4 PI 32.5 24.4 19.94 0.431 10.7 10.8 5.821 0.969
8 PI 57.3 39.1 25.86 0.18 18.5 17.6 6.763 0.801
Total SCFA, μmol/g
4 PI 98 88 37.1 0.613 107 102 21.5 0.606
8 PI 147 136 17.6 0.244 155 163 21.5 0.461
Acetic acid, %
4 PI 55.8 55.2 8.22 0.892 60.5 60.1 6.01 0.907
8 PI 56.0 54.2 7.37 0.629 61.3 60.2 4.06 0.573
Propionic acid, %
4 PI 26.6 24.6 3.86 0.317 22.5 24.7 5.91 0.479
8 PI 21.7 25.9 6.52 0.218 22.6 23.1 3.32 0.778
Butyric acid, %
4 PI 12.9 14.3 6.01 0.649 12.6 11.2 3.78 0.492
8 PI 17.0 15.3 3.61 0.373 13.5 12.7 2.09 0.452
Valeric acid, %
4 PI 2.65 4.10 1.804 0.118 2.73 2.55 1.327 0.802
8 PI 4.10 3.53 1.467 0.456 1.59 2.84 1.056 0.033
BCFA, %
4 PI 2.16 1.83 1.186 0.586 1.68 1.37 0.774 0.465
8 PI 1.27 1.11 0.531 0.566 0.95 1.21 0.365 0.176
BCFA Branched-chain fatty acids, PI Post-inoculation day, RSE Residual standard
error, SCFA Short-chain fatty acids
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During the week of adaptation after weaning, ani-
mals from the different diets displayed similar perfor-
mances, with no influence of DIC supplementation.
Other authors, however, have described improvements
in performance related to the supplementation of
MCFA. Some works evaluating MCFA as an energy
source, at higher doses (2.1–7.75%), registered growth
improvements [6, 13, 46, 47] that could be justified
by the more rapid digestion and absorption of these
fatty acids. Improvements have also been seen in ani-
mals challenged with ETEC F4 or LPS [23, 48], how-
ever, not necessarily by using high doses. Regarding
the possible effects of MCFA supplementation on feed
intake, we did not detect any impact of the experi-
mental diets. The potential impact of MCFA as
additives on feed intake is controversial. When sup-
plemented at high levels, as a rapid source of energy,
MCFA could prompt satiety due to their rapid oxida-
tion in the liver [49, 50]. Moreover, MCFA have also
been described as rancid and presenting low palatabil-
ity [51, 52], which could therefore lead to a decline
in feed intake and impair the adaptation to dry feed
after weaning. Nonetheless, in our study, there was
no negative impact of DIC on the feed intake during
the first week post-weaning. The lower dosage (at
0.3%) than that used in other studies, and the differ-
ent nature and composition of MCFA blends, could
explain the discrepancies with other studies.
One of the most remarkable effects of this study was
the specific action of supplemented MCFA on popula-
tions of Salmonella, coliforms, and enterobacteria.
Salmonella spp. counts in the cecum tended to be
reduced by DIC, despite a higher initial colonization
after the challenge. After the ETEC F4 inoculation, DIC
consistently diminished the enterobacteria and total coli-
form populations in the luminal content of the ileum
and colon (particularly on d 8 PI), and the same trend
was observed in the ileal mucosa, despite the effects on
the luminal E. coli F4 pathogen being small. As stated in
the introduction, a higher antibacterial activity has been
described for MCFA than other free fatty acids [53].
Most recent studies have demonstrated their in vitro ac-
tivity against a wide range of pathogenic bacteria [5, 11,
53, 54]. Lauric acid (C12) has been shown to have the
highest antimicrobial activity among the fatty acids
present in coconut oil [54, 55]. However, other medium-
chain fatty acids, caprylic acid (C8) and capric acid
(C10), showed the highest antimicrobial activity against
different E. coli and Salmonella strains tested [3]. Freese
et al. [56] and Sheu et al. [57] also reported lower mini-
mum inhibitory concentrations (MIC) of caproic (C6)
and caprylic (C8) acids for 50% growth inhibition of E.
coli than capric acid (C10) and C12. Furthermore, C6
and C8 have been selected for their antimicrobial activ-
ity, rather than longer-chain fatty acids, to be tested in
in vivo trials [23]. Nevertheless, although C12 is the
major compound in the distillates of coconut (48.4%
crude fat, CF), these also include important proportions
of other MCFA (6.2% CF for C8 and 5.8% CF for C10)
that might support the aforementioned effects.
Among the in vivo studies that have evaluated the ef-
fect of MCFA administration on pathogens, some au-
thors have described lower numbers of clostridia or E.
coli [15, 16, 58–60], and also Salmonella [22]. These re-
ported effects on the colonization of the gut by different
pathogens could have been mediated by the direct activ-
ity of MCFA, but also indirectly, by changes promoted
by these additives in the intestinal microbiota. In this re-
gard, different in vivo trials in pigs have described sig-
nificant changes in bacterial populations promoted by
the direct supplementation of MCFA supplementation
[61, 62], including a transgenerational influence ob-
served by the supplementation of sows having an effect
on their offspring [63]. The variability in these effects in
the literature could be the result of differences between
MCFA sources, blends, dosages, and methods of admin-
istration, making the direct comparison between studies
difficult. In particular, most of the experimental blends
tested were composed of a combination of C8 and C10
and negligible quantities of C12, or their conjugated
forms, into triacylglycerol (MCT), with lipases needed to
release, not always successfully, the free fatty acids.
Table 8 Effects of the experimental diets on histomorphometry
in the ileum in the Salmonella and ETEC F4 trials
Items Salmonella trial ETEC F4 trial
CTR DIC RSE P CTR DIC RSE P
Villus height, μm
4 PI 185 183 65.5 0.962 278 229 89.4 0.289
8 PI 282 276 58.1 0.852 323 321 63.7 0.955
Crypt depth, μm
4 PI 315 323 69.6 0.815 196 182 30.9 0.38
8 PI 300 290 37.1 0.596 189 184 19.7 0.600
Villus:Crypt
4 PI 0.60 0.63 0.257 0.841 1.47 1.29 0.469 0.454
8 PI 0.99 0.99 0.209 0.944 1.78 1.79 0.364 0.935
MIT, cells/100 μm
4 PI 0.251 0.325 0.160 0.39 0.078 0.068 0.103 0.845
8 PI 0.075 0.099 0.082 0.569 0.104 0.091 0.141 0.862
GC, cells/100 μm
4 PI 2.20 1.93 0.851 0.556 1.75 1.43 0.542 0.262
8 PI 1.49 1.28 0.548 0.457 1.31 1.33 0.519 0.954
IEL, cells/100 μm
4 PI 2.92 2.76 1.509 0.841 2.07 2.04 0.482 0.917
8 PI 3.92 3.06 0.882 0.072 2.39 2.88 0.523 0.080
GC Goblet cells in the villus, IEL Intraepithelial lymphocytes in the villus, MIT
Mitoses in the crypt, PI Post-inoculation day, RSE Residual standard error
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To our knowledge, very few works have evaluated the
effect of MCFA on intestinal microbiota by performing
an entire profiling of their populations, particularly when
faced with a pathogen challenge. The results of our work
show that, in global terms, the microbiota profiles ob-
served after the two challenges were not substantially
different from those previously described for piglets of
this age [64, 65], suggesting that these animals did not
suffer any drastic dysbiosis. In fact, other challenges in
piglets with Salmonella could not differentiate clusters
from unchallenged and Salmonella-challenged animals
either [66], and were not even able to detect the Salmon-
ella genus by HTS, as occurred in our animals. Never-
theless, it must be taken into account that the activity of
the supplemented MCFA against potential pathogens
was observed mainly in the ileum and cecum, and the
assortment of microbial populations was also affected.
This leads us to hypothesize that the direct impact on
upper parts of the gut is reflected, for instance, on the
gastric barrier or the small intestine in the foregut.
Nevertheless, there were still observed microbiota
changes promoted by DIC diets. In both trials, the
DIC diets were able to significantly modify particular
microbial taxa, although the affected bacterial groups
were different. With the Salmonella challenge, the
most relevant change was a significant increase
registered in the Fibrobacteres phylum (P = 0.019).
Accompanied by a (numerical) reduction in Entero-
bacteriaceae, it could be hypothesized that the sup-
plemented MCFA prompts a more fibrolytic-like
adult microbial profile. In addition, it is interesting
to remark that several OTUs from the Lachnospira-
ceae family were decreased with the DIC diet com-
pared to the CTR diet and that the Lachnospira
genus has been reported to increase with the pres-
ence of Salmonella [67]. This response of the micro-
biota to DIC supplementation could also be
associated with the response registered in IEL at the
ileal level. On d 8 PI, the animals treated with DIC
and challenged with Salmonella maintained lower
numbers of IEL than the CTR group. A possible hy-
pothesis is that the pigs in the DIC group might
have retained a more benign environment within the
gastrointestinal tract. Another plausible explanation
could be that the clear reduction in the pathogen
counts in the cecum by the addition of DIC stopped
the recruitment of IELs, since these defense cells
have been found near Salmonella pathogens [68]. In
fact, the IEL counts were higher within the Salmon-
ella challenge than in previous trials in our group
[33, 69], reflecting a more acute course of diarrhea.
If we consider that the IELs remain quiescent until
facing a real threat [70], it seems reasonable that
after the Salmonella challenge, DIC treatment had
the opportunity to show its effects on the current
IEL response.
However, within the ETEC F4 trial, the reduction in
possible specific commensal populations such as entero-
bacteria and coliforms as observed in the ETEC F4-
challenged animals, might suggest a more hostile milieu,
which consequently mobilized more IELs than the CTR
group. In turn, the IEL response could also be related to
a possible readaptation of the community structure, as
seen in the NMDS results (envfit P = 0.035). In this re-
gard, the impact of the MCFA supplementation was evi-
dent at the structural level, with the most relevant
change in the bacterial groups observed for the increase
in Dialister (P = 0.008) within the Veillonellaceae family.
However, other mechanisms related to a direct modula-
tor effect of MCFA on the immune response of the ani-
mal should not be disregarded. MCFA supplemented to
pre-weaning piglets as triglycerides (MCT) have been
shown to stimulate the immune response in the stom-
ach, regardless of the complexity of the microbiota [71].
In addition, similar stimulatory effects on intestinal villi
and the local immunity have been demonstrated in LPS-
challenged weanlings based on C6- and C8-MCT [23].
To try and elucidate possible associations between the
microbial populations and gut variables assessed in this
study, particularly those modified by the experimental
treatments, we performed a correlation analysis; the
most relevant correlations (r > 0.5 and adjusted P <
0.10) are presented in Table 9. Interestingly, candidate
Barnesiellaceae and Enterobacteriaceae families were
positively correlated with the IEL counts in the Salmon-
ella trial, whereas in the ETEC F4 trial, no significant
correlation was found. This could be somehow related
to the differential response registered in IEL with DIC
between both trials. Valeric acid showed only a signifi-
cant high inverse correlation with Clostridiaceae (P =
0.011) in the Salmonella trial. Under the ETEC F4
Table 9 Pearson’s correlationsa between gut variables and
bacterial populations for Salmonella and ETEC F4 trials
Gut variable Microbiotab Pearson (r) Adjusted P
Salmonella trial
IEL candidate Barnesiellaceae 0.698 0.055
IEL candidate Odoribacteraceae 0.694 0.057
IEL Odoribacter 0.694 0.057
IEL Enterobacteriaceae 0.686 0.065
Valeric acid Clostridiaceae -0.782 0.011
ETEC F4 trial
Valeric acid Megasphaera 0.837 0.005
Valeric acid Veillonellaceae 0.784 0.023
IEL Intraepithelial lymphocytes in the ileal villus
aCorrelations considered: r > 0.5 and adjusted P < 0.10
bMicrobial populations identified by high-throughput sequencing (HTS)
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challenge, valeric acid was positively correlated with
Megasphaera (r = 0.837) and the corresponding family
Veillonellaceae (r = 0.784). This correlation is coincident
with the higher presence of Dialister on d 8 PI in DIC
animals and the higher percentage of valeric acid than in
CTR animals. Dialister and Megasphaera, among other
members within the Veillonellaceae family, have been
reported to produce valeric acid as an end metabolite of
the fermentation of carbohydrates and lactate [72].
Conclusions
The results obtained from this study support the activity
of a blend of sodium salts of coconut oil distillates in re-
ducing the hindgut colonization by pathogenic popula-
tions such as enterobacteria, E. coli, and Salmonella in
orally-challenged weaned piglets. The effects could be
mediated by the changes promoted in the microbiota
ecosystem since significant effects were registered in dif-
ferent microbial groups. Under a Salmonella challenge,
significant increases were registered in the Fibrobacteres
phylum and after an ETEC F4 challenge, the most rele-
vant changes were registered in the Dialister genus of
the Veillonellaceae family within a diverging microbial
structure. There was also a differential impact of this
blend on the intestinal local immune response, leading
to higher numbers of ileal intraepithelial lymphocytes
after the Salmonella challenge, but lower numbers after
the ETEC F4 challenge. The effects of the supplemented
MCFA might respond to different complex interactions
between the opportunistic pathogens, the commensal
microbiota and the host response.
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